Darbesis Injection 25 mcg/0.42 ml contains Darbepoetin Alfa, a long-acting erythropoiesis-stimulating agent (ESA) used for the treatment of anemia, particularly in patients with chronic kidney disease (CKD) and those undergoing chemotherapy. It helps stimulate the production of red blood cells, thereby increasing hemoglobin levels and reducing the need for blood transfusions.

This lower-strength formulation is suitable for initiating therapy, dose titration, and maintenance treatment under medical supervision.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

Each prefilled syringe contains:

• Darbepoetin Alfa 25 mcg in 0.42 ml

Mechanism of Action

Darbepoetin Alfa is a recombinant erythropoietin analog with an extended half-life. It binds to erythropoietin receptors on erythroid progenitor cells in the bone marrow, stimulating their proliferation and differentiation into mature red blood cells. This results in improved oxygen-carrying capacity and correction of anemia.

Indications

Darbesis Injection 25 mcg/0.42 ml is indicated for:

• Anemia associated with chronic kidney disease (CKD)
• Anemia in patients receiving chemotherapy for non-myeloid cancers
• Reduction of the need for blood transfusions
• Maintenance therapy in patients requiring ongoing erythropoietic support

Dosage and Administration

• Administered by subcutaneous (SC) or intravenous (IV) injection under medical supervision
• Dosage is individualized based on body weight, hemoglobin levels, and patient response
• Typically administered once weekly or once every two weeks
• Regular monitoring of hemoglobin levels is required
• Dose adjustments should be made carefully to maintain target hemoglobin levels

Contraindications

Darbesis Injection should not be used in:

• Known hypersensitivity to Darbepoetin Alfa or erythropoietin products
• Uncontrolled hypertension
• Pure red cell aplasia following ESA therapy
• Severe allergic reactions to formulation components

Side Effects

Possible side effects include:

• Increased blood pressure
• Headache
• Injection site reactions
• Edema (fluid retention)
• Thromboembolic events (e.g., deep vein thrombosis)
• Fever or flu-like symptoms
• Rare hypersensitivity reactions

Precautions

• Ensure blood pressure is controlled before initiating therapy
• Monitor hemoglobin regularly to avoid excessive elevation
• Maintain adequate iron levels for optimal effectiveness
• Use cautiously in patients with cardiovascular disease or history of stroke
• Should be used under strict medical supervision

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Drug Interactions

Darbesis Injection may interact with:

• Iron supplements (commonly co-administered)
• Antihypertensive medications
• Other drugs affecting red blood cell production

Storage Conditions

• Store at 2°C to 8°C in a refrigerator
• Do not freeze or shake
• Protect from light
• Keep out of reach of children.